Skip to content

Smoking threatens health gains from hepatitis C treatment, US researchers warn

Lymphoma treatment outcomes just as good for people with HIV

Severe fibrosis improves in most people after hepatitis C cure but persists in a quarter

HPV16 highly prevalent among HIV-positive MSM in France and strongly associated with high-grade pre-cancerous anal lesions

PrEP does not raise lipids or alter body fat, safety study finds

Zambia: HIV deaths on treatment underestimated

Darunavir/ritonavir most durable boosted protease inhibitor in European patients, especially those switching treatment for any reason

High prevalence of hypertension among HIV-positive people in the US with 'missed opportunities' for its diagnosis and control

Communication skills training for healthcare workers improves HIV treatment adherence